1. Home
  2. XNCR vs GCT Comparison

XNCR vs GCT Comparison

Compare XNCR & GCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XNCR
  • GCT
  • Stock Information
  • Founded
  • XNCR 1997
  • GCT 2019
  • Country
  • XNCR United States
  • GCT United States
  • Employees
  • XNCR 250
  • GCT N/A
  • Industry
  • XNCR Biotechnology: Pharmaceutical Preparations
  • GCT Catalog/Specialty Distribution
  • Sector
  • XNCR Health Care
  • GCT Consumer Discretionary
  • Exchange
  • XNCR Nasdaq
  • GCT Nasdaq
  • Market Cap
  • XNCR 625.6M
  • GCT 502.5M
  • IPO Year
  • XNCR 2013
  • GCT 2022
  • Fundamental
  • Price
  • XNCR $8.20
  • GCT $18.29
  • Analyst Decision
  • XNCR Buy
  • GCT Strong Buy
  • Analyst Count
  • XNCR 9
  • GCT 3
  • Target Price
  • XNCR $30.13
  • GCT $36.67
  • AVG Volume (30 Days)
  • XNCR 970.6K
  • GCT 843.1K
  • Earning Date
  • XNCR 05-07-2025
  • GCT 05-12-2025
  • Dividend Yield
  • XNCR N/A
  • GCT N/A
  • EPS Growth
  • XNCR N/A
  • GCT 19.58
  • EPS
  • XNCR N/A
  • GCT 3.07
  • Revenue
  • XNCR $127,228,000.00
  • GCT $1,181,871,000.00
  • Revenue This Year
  • XNCR N/A
  • GCT $3.01
  • Revenue Next Year
  • XNCR $25.05
  • GCT $6.52
  • P/E Ratio
  • XNCR N/A
  • GCT $5.93
  • Revenue Growth
  • XNCR N/A
  • GCT 42.89
  • 52 Week Low
  • XNCR $7.16
  • GCT $11.17
  • 52 Week High
  • XNCR $27.24
  • GCT $41.10
  • Technical
  • Relative Strength Index (RSI)
  • XNCR 37.73
  • GCT 71.30
  • Support Level
  • XNCR $7.89
  • GCT $12.88
  • Resistance Level
  • XNCR $9.37
  • GCT $18.99
  • Average True Range (ATR)
  • XNCR 0.83
  • GCT 0.85
  • MACD
  • XNCR -0.13
  • GCT 0.69
  • Stochastic Oscillator
  • XNCR 9.09
  • GCT 89.71

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

About GCT GigaCloud Technology Inc

GigaCloud Technology Inc provides end-to-end and B2B e-commerce solutions for large parcel merchandise. Its B2B e-commerce platform, which is referred to as the GigaCloud Marketplace, integrates everything from discovery, payments, and logistics tools into one easy-to-use platform. It offers online and offline integrated cross-border transaction and delivery services for furniture and large merchandise. Its marketplace seamlessly connects manufacturers in Asia, with resellers in the U.S., Asia, and Europe, to execute cross-border transactions with confidence, speed, and efficiency. It offers a truly comprehensive solution that transports products from the manufacturer's warehouse to end customers, all at one fixed price.

Share on Social Networks: